This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of FNP-223 (oral formulation) in slowing the progression ...
Progressive supranuclear palsy (PSP), a mysterious and deadly neurological disorder, usually goes undiagnosed until after a patient dies and an autopsy is performed. But now, UC San Francisco ...
LILLE, France--(BUSINESS WIRE)--Alzprotect, a French biopharmaceutical company, is pleased to announce the successful completion of the open-label extension (OLE) phase following the Phase 2a clinical ...
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Donohue - Please explain progressive supranuclear palsy. Is it hereditary? What causes it, and what are its symptoms?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results